CLARKE ANDREW C

Director Clarke buys 600 shares of PKOH at $19.75 (stock now $20.18, down 39.7% from 52-week high)

Andrew C. Clarke, a director, purchased 600 shares at $19.75 on 2025-11-12, increasing his stake from 14.8K shares to 15.4K shares. The stock trades at $20.18 today, only slightly above the purchase price, while sitting 39.7% below its 52-week high of $33.48. Clarke's cross-ticker track record shows 2 prior open-market buys with a 0.00% win rate on the 90-day horizon (avg 90d return -5.1%), suggesting his recent purchases have not captured subsequent gains. The company's fundamentals are modest—$398.6M quarterly revenue with flat annual growth (-0.2%) and a P/E of 12.46 at a $290.7M market cap—offering neither momentum nor distress signals to frame this modest accumulation.

Director Andrew C Clarke bought 5,000 LKQ shares at $31.95 on 2025-08-27, raising holdings 30.9% to 21,172 shares.

Director Clarke purchased 5,000 shares at $31.95, a price $0.13 below the current market price of $32.08, though the stock is -27.2% from its 52-week high of $44.05. His cross-ticker track record shows 1 prior buy with an average 90-day return of -5.1%, and his specific prior trade at LKQ (bought 2024-07-26) also returned -5.1% over 90 days, indicating a pattern of poorly timed entries at this ticker. The company's fundamentals are stable with P/E of 11.62, $3.6B quarterly revenue, and annual growth of +3.5%, but this purchase follows an insider whose timing has not proven reliable. This transaction raises Clarke's stake by 30.9% from 16.2K to 21.2K shares.

Director Clarke bought 7,600 shares of LKQ at $39.70 on 2024-07-26; stock now -30.1% from 52-week high, cluster buy pattern with 3 other insiders in 14 days.

CLARKE ANDREW C, a Director, acquired 7,600 shares for $301,713.16, increasing holdings by +260.4% from 2,919 to 10,519 shares. The purchase occurred when LKQ was trading at $39.70, currently -30.1% below its 52-week high of $57.45 and -3.4% lower over the past 30 days. This buy coincides with a cluster pattern: 3 other insiders have also purchased within the same 14-day window, suggesting coordinated confidence at current valuation levels. With LKQ trading at 14.50 P/E on $3.7B quarterly revenue and +8.4% annual growth, the multiple accumulation by multiple insiders warrants attention to whether this reflects emerging board-level conviction or represents opportunistic accumulation during a period of price weakness.